Suresh Balakrishnan

15PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyMolecular targetsNeonatologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 10, 2026
4-FPAC-Modulated Tumor-Associated Macrophage Conditioned Media Suppresses Malignant Phenotypes and Promotes Cell-Cycle Arrest and Apoptosis in NSCLC.

|Mar 22, 2026
Amiodarone disrupts thyroid hormone homeostasis and impairs myogenic progression and locomotor function in zebrafish embryos.

Juhi Vaishnav, Abhinav Upadhyay, Arya Bhatt

|Sep 13, 2025
Thyroid hormone receptor blockade by amiodarone disrupts angiogenesis via VEGFα, WNT7A, BMP, and PI3K/AKT pathways in chick embryo vascular development.

Juhi Vaishnav, Suresh Balakrishnan

|Aug 25, 2025
Thyroid Hormone Deficiency Disrupts Embryonic Ventral Body Wall Development and Myogenesis With Partial Recovery Following LevothyroxineTherapy.

Juhi Vaishnav, Suresh Balakrishnan

|Aug 05, 2025
Sublethal Exposure to a Chlorpyrifos-Cypermethrin Mixture Disrupts Limb Development and Causes Severe Skeletal Abnormalities in Domestic Chick Embryos.

Shashikant Sharma, Juhi Vaishnav, Pooja Raval

|Apr 23, 2025
4-fluorophenylacetamide acetyl coumarin induces pro-inflammatory M1 macrophage polarization and suppresses the immunosuppressive M2 phenotype through PI3k/AKT/NF-κB modulation.

Anjali Singh, Lakshmi Pillai, Dhanush Danes

Pageof 3

Frequent Collaborators

2 joint publications

Sonam Patel

2 joint publications

Dhanush Danes

2 joint publications

Juhi Vaishnav

1 joint publications

Isha Ranadive